These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 29733853)
1. p73 Alternative Splicing: Exploring a Biological Role for the C-Terminal Isoforms. Vikhreva P; Melino G; Amelio I J Mol Biol; 2018 Jun; 430(13):1829-1838. PubMed ID: 29733853 [TBL] [Abstract][Full Text] [Related]
2. p73: From the p53 shadow to a major pharmacological target in anticancer therapy. Ramos H; Raimundo L; Saraiva L Pharmacol Res; 2020 Dec; 162():105245. PubMed ID: 33069756 [TBL] [Abstract][Full Text] [Related]
3. P73 C-terminus is dispensable for multiciliogenesis. Buckley N; Panatta E; Morone N; Noguchi M; Scorrano L; Knight RA; Amelio I; Melino G Cell Cycle; 2020 Jul; 19(14):1833-1845. PubMed ID: 32584647 [TBL] [Abstract][Full Text] [Related]
4. Tissue-specific roles of p73 in development and homeostasis. Nemajerova A; Moll UM J Cell Sci; 2019 Oct; 132(19):. PubMed ID: 31582429 [TBL] [Abstract][Full Text] [Related]
5. Non-oncogenic roles of TAp73: from multiciliogenesis to metabolism. Nemajerova A; Amelio I; Gebel J; Dötsch V; Melino G; Moll UM Cell Death Differ; 2018 Jan; 25(1):144-153. PubMed ID: 29077094 [TBL] [Abstract][Full Text] [Related]
6. p63 and p73: roles in development and tumor formation. Moll UM; Slade N Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445 [TBL] [Abstract][Full Text] [Related]
8. The C terminus of p53 family proteins is a cell fate determinant. Harms KL; Chen X Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654 [TBL] [Abstract][Full Text] [Related]
9. ∆Np73 is capable of inducing apoptosis by co-ordinately activating several BH3-only proteins. Sánchez-Carrera D; García-Puga M; Yáñez L; Romón Í; Pipaón C Biosci Rep; 2015 Apr; 35(3):. PubMed ID: 26182360 [TBL] [Abstract][Full Text] [Related]
10. Tissue-specific expression of p73 and p63 isoforms in human tissues. Marshall CB; Beeler JS; Lehmann BD; Gonzalez-Ericsson P; Sanchez V; Sanders ME; Boyd KL; Pietenpol JA Cell Death Dis; 2021 Jul; 12(8):745. PubMed ID: 34315849 [TBL] [Abstract][Full Text] [Related]
11. The C terminus of p73 is essential for hippocampal development. Amelio I; Panatta E; Niklison-Chirou MV; Steinert JR; Agostini M; Morone N; Knight RA; Melino G Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15694-15701. PubMed ID: 32571922 [TBL] [Abstract][Full Text] [Related]
12. p73 plays a role in erythroid differentiation through GATA1 induction. Marqués-García F; Ferrandiz N; Fernández-Alonso R; González-Cano L; Herreros-Villanueva M; Rosa-Garrido M; Fernández-García B; Vaque JP; Marqués MM; Alonso ME; Segovia JC; León J; Marín MC J Biol Chem; 2009 Aug; 284(32):21139-56. PubMed ID: 19509292 [TBL] [Abstract][Full Text] [Related]
13. The role of the TP73 gene and its transcripts in neuro-oncology. Jancalek R Br J Neurosurg; 2014 Oct; 28(5):598-605. PubMed ID: 24742294 [TBL] [Abstract][Full Text] [Related]
14. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo. Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898 [TBL] [Abstract][Full Text] [Related]
15. Negative autoregulation of p73 and p53 by DeltaNp73 in regulating differentiation and survival of human neuroblastoma cells. Nakagawa T; Takahashi M; Ozaki T; Watanabe K; Hayashi S; Hosoda M; Todo S; Nakagawara A Cancer Lett; 2003 Jul; 197(1-2):105-9. PubMed ID: 12880968 [TBL] [Abstract][Full Text] [Related]
16. Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations. Faridoni-Laurens L; Tourpin S; Alsafadi S; Barrois M; Temam S; Janot F; Koscielny S; Bosq J; Bénard J; Ahomadegbe JC Cell Cycle; 2008 Jun; 7(11):1587-96. PubMed ID: 18469517 [TBL] [Abstract][Full Text] [Related]
17. TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity. Tomasini R; Seux M; Nowak J; Bontemps C; Carrier A; Dagorn JC; Pébusque MJ; Iovanna JL; Dusetti NJ Oncogene; 2005 Dec; 24(55):8093-104. PubMed ID: 16044147 [TBL] [Abstract][Full Text] [Related]
18. TP53 family members and human cancers. Bénard J; Douc-Rasy S; Ahomadegbe JC Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104 [TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo. Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298 [TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase inhibitors differentially modulate p73 isoforms in neuroblastoma. Lau LM; Wolter JK; Lau JT; Cheng LS; Smith KM; Hansford LM; Zhang L; Baruchel S; Robinson F; Irwin MS Oncogene; 2009 May; 28(19):2024-33. PubMed ID: 19363520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]